pfizer glp 1 weight loss has released promising mid-stage Phase IIb trial data for its obesity treatment, PF-3944. This long-acting GLP-1 injectable demonstrated an impressive 12.3% placebo-adjusted at 28 weeks with monthly dosing, positioning GLP-1 weight-loss drugs market 'almost

A realistic way to think about GLP-1 medications: They improve the environment around lipedema (not the diseased tissue itself) GLP-1 belongs in the category of supportive tools similar to anti-inflammatory diet, metabolic care, and mobility support

Skip your next scheduled dose and resume your regular schedule the following week

At Beauty Innovations in Marina del Rey, we are seeing more clients seeking solutions to restore the structure and radiance that rapid body transformation can sometimes diminish

Discussions of the exact egg development and hatching cycle of the Gila monster came to an abrupt and unexpected end on October 28, 2016, when a backhoe was digging at the outer walls of a house in a suburb of northern Tucson